Kobayashi Pharma Of Japan To Sell Drugs Via Internet, Mail Order
This article was originally published in PharmAsia News
Japan's Kobayashi Pharmaceutical says it plans to expand its mail order and Internet sales business to include its drugs for treating cholesterol, pain and flatulence beginning in September.
You may also be interested in...
India’s Cadila Healthcare, which has been suffering on the earnings front, is amalgamating four subsidiaries under its roof to reduce overheads from managing separate entities and avoid duplication of efforts after posting weak second-quarter earnings.
GemVax unveils positive topline results for South Korean Phase II study of novel peptide drug targeting patients with moderate to severe Alzheimer’s disease, raising hopes for the upcoming US trials.